Lee’s Summit Medical Center contributes to study which may change infection prevention

June 26, 2013 

Lee’s Summit Medical Center participated in a comprehensive infection prevention study that suggests a major change in healthcare practice could improve the quality of care in every hospital and save lives.

As a result of the findings in a 43-hospital study, HCA is in the process of implementing universal decolonization in its adult intensive care units in each of its hospitals.

The use of antimicrobial agents on an entire patient population is called “universal decolonization.” The recent study found that using antimicrobial soap and ointment to decolonize all intensive care unit patients reduced all bloodstream infections, including MRSA by 44 percent.

Known as Randomized Evaluation of Decolonization Versus Universal Clearance to Eliminate (REDUCE) MRSA, the study was conducted in conjunction with investigators at Harvard and several other academic institutions, and research programs at two U.S. Department of Health and Human Services agencies, the Agency for Healthcare Research and Quality (AHRQ) and the Centers for Disease Control and Prevention (CDC).

“HCA and its hospitals nationwide are continuously seeking ways to provide the highest quality patient care possible,” says Darryl Nelson, a physician and HCA Midwest Health System Chief Medical Officer. “It is our commitment to continually improve our high standards of care to give patients the best outcome possible. We are pleased four HCA Midwest Health System hospitals participated in this groundbreaking study.”

Lee’s Summit Medical Center, Belton Regional Medical Center, Menorah Medical Center and Overland Park Regional Medical Center, part of HCA Midwest Health System are local hospitals that participated in the study made exclusively at HCA-affiliated hospitals nationwide and recently published in the New England Journal of Medicine.

“The REDUCE MRSA study proved that universal decolonization is the best practice to prevent infection from MRSA and other dangerous bacteria in high risk ICU patients,” said Jonathan B. Perlin, a doctor and President, Clinical and Physician Services Group and Chief Medical Officer of HCA. “These compelling results convinced us to implement this protocol in HCA hospital adult ICUs. Universal decolonization should be a new part of a comprehensive infection prevention effort that begins with hand hygiene and includes a number of proven practices.”

The study, which involved nearly 75,000 patients and more than 280,000 patient days in 74 adult ICUs located in 16 states, compared the results of three approaches in ICUs:

Screen all patients and isolate MRSA carriers

• Targeted decolonization: screening, isolation, and decolonization of MRSA carriers with chlorhexidine and mupirocin ointment

• Universal decolonization, no screening and all patients decolonized with chlorhexidine and nasal mupirocin ointment.

The REDUCE MRSA team found that using universal decolonization reduced MRSA clinical cultures by 37 percent. Patients colonized with MRSA may not be sick, but they are at risk for later illness and for spreading it to others. All bloodstream infections were decreased by 44 percent. The researchers noted that this trial took place in HCA hospitals, mostly in community hospitals, rather than academic institutions and conducted by hospital personnel rather than specially trained research staff. Therefore, unlike some clinical studies, these results are likely to be applicable to nearly all U.S. hospitals.

“It is exciting that Lee’s Summit Medical Center was part of this national practice-changing health care study,” said Jackie DeSouza, Lee’s Summit Medical Center CEO, “The implementation of new standards of care based on the results of this study can positively impact hospital patients far beyond the walls of Lee’s Summit Medical Center. This is very good news for patient care.”

"This study demonstrates what can be accomplished for patient safety when we create the right partnerships,” said John Jernigan, Director of CDC’s Office of Prevention Research and Evaluation and head of CDC’s Prevention Epicenters Program. “This unique collaboration between public health scientists, academic investigators and private hospitals allowed us to take novel infection prevention strategies to patients’ bedside. With these critical partnerships, we can better protect patients and make healthcare safer.”

Lee's Summit Journal is pleased to provide this opportunity to share information, experiences and observations about what's in the news. Some of the comments may be reprinted elsewhere in the site or in the newspaper. We encourage lively, open debate on the issues of the day, and ask that you refrain from profanity, hate speech, personal comments and remarks that are off point. Thank you for taking the time to offer your thoughts.

Commenting FAQs | Terms of Service